trans-2-Pentenal

We are trans-2-Pentenal CAS:1576-87-0 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:trans-2-Pentenal
CAS.NO:1576-87-0
Synonyms:trans-2-Pentenal
2-(E)-pentenal
pent-2-enal
trans-2-penten-1-one
(E)-2-pentenal
(E)-2-penten-1-al
 
Physical and Chemical Properties:
Density 0.8±0.1 g/cm3
Boiling Point 126.8±0.0 °C at 760 mmHg
Molecular Formula C5H8O
Molecular Weight 84.116
Flash Point 22.8±0.0 °C
 
Specification:
Appearance:Colorless transparent liquid
Assay:≥99.0%
 
Packing:200 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Flavors and fragrances intermediate

trans-2-Pentenal


Related News: As proof-of-principle for the unique advantages arising from selecting a single engineered iPSC clone for the production of CAR T-cell therapy, the scientists assessed 747 clones after engineering a pool of cells using CRISPR. It was found that only about 2% of clones met the Company’s standards for overall quality including containing both bi-allelic disruption of the TCR, proper insertion of the CAR into the TRAC locus without random transgene integrations, and no evidence of off-target genomic modifications or translocations.2-Chloro-4,6-diphenyl-1,3,5-triazine CAS:3842-55-5 On the basis of achieving low-cost and high-quality processes, production capacity will become the core driving force for API companies to break through sales bottlenecks.(5-formylfuran-2-yl)boronic acid There are however certain APIs that are unknown and so require additional substances that work in conjunction with the API to produce the required effect.1,2-pentanodiol CAS:5343-92-0 Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.Green Valley said it would launch the drug “very soon” in China. The company also aims to roll out a phase-3 clinical trial with sites in the United States, Europe and Asia in early 2020 to facilitate global regulatory approval of the drug.

Related Products
Product Name
Fmoc-D-Arg(pbf)-OH View Details
2-Amino-3-bromo-5-methylpyridine View Details
2-Fluoro-4-nitroaniline View Details
3-(2-Methoxy-5-methylphenyl)-3-phenyl-propanoic Acid manufacturer 3,4-Difluorophenyl isothiocyanate manufacturer 2-N-Cyclopropylamino-4,6-DichloroTriazine manufacturer ADENOSINE5′-MONOPHOSPHATESODIUMSALT manufacturer SL007 Preservative Cas:78491-02-8_55406-53-6 manufacturer